News und Analysen
Is Pfizer Winning Its $43 Billion Bet?
Pfizer (NYSE: PFE) is one of the most successful pharmaceutical companies ever. In 2022, it brought in more than $100 billion in revenue -- a record for itself and for the entire industry. Of
Is Pfizer Winning Its $43 Billion Bet?
Pfizer (NYSE: PFE) is one of the most successful pharmaceutical companies ever. In 2022, it brought in more than $100 billion in revenue -- a record for itself and for the entire industry. Of
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2024 Earnings CallAug 01, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2024 Earnings CallAug 01, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2024 Earnings CallAug 01, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Biogen (BIIB) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Biogen (BIIB) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Biogen (BIIB) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Cigna Group (CI) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Cigna Group (NYSE: CI)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
Great companies can deliver meaningful portfolio growth in a wide range of economic and market environments. From established companies to emerging businesses, the types of stocks you favor will
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
Great companies can deliver meaningful portfolio growth in a wide range of economic and market environments. From established companies to emerging businesses, the types of stocks you favor will
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
Great companies can deliver meaningful portfolio growth in a wide range of economic and market environments. From established companies to emerging businesses, the types of stocks you favor will
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
Pfizer (NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021.
However, the
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
Pfizer (NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021.
However, the
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Investors who buy stocks through both bull and bear markets are the ones who tend to benefit more in the long term because they are growing their portfolios consistently. But a bull market does seem
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Investors who buy stocks through both bull and bear markets are the ones who tend to benefit more in the long term because they are growing their portfolios consistently. But a bull market does seem
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
The anti-obesity drug market could be worth a staggering $100 billion, according to some analysts. That's a huge growth opportunity, and it's a reason why many top drugmakers in the world are
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
The anti-obesity drug market could be worth a staggering $100 billion, according to some analysts. That's a huge growth opportunity, and it's a reason why many top drugmakers in the world are
Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy?
Just a couple of years ago, Pfizer's (NYSE: PFE) revenue was soaring thanks to sales of its coronavirus vaccine. In fact, the vaccine became the world's best-selling pharmaceutical product and even
Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy?
Just a couple of years ago, Pfizer's (NYSE: PFE) revenue was soaring thanks to sales of its coronavirus vaccine. In fact, the vaccine became the world's best-selling pharmaceutical product and even
Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q2 2024 Earnings CallJul 31, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Is The Trade Desk Stock Going to $105? 1 Wall Street Analyst Thinks So
Next-generation digital advertising platform developer The Trade Desk (NASDAQ: TTD) is an out-of-favor stock that should be getting more investor love. That's according to one pundit following the
Pfizer (PFE) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Pfizer (NYSE: PFE)Q2 2024 Earnings CallJul 30, 2024, 10:30 a.m. ET
Operator
Source Fool.com
Pfizer (PFE) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Pfizer (NYSE: PFE)Q2 2024 Earnings CallJul 30, 2024, 10:30 a.m. ET
Operator
Source Fool.com
Merck (MRK) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q2 2024 Earnings CallJul 30, 2024, 9:00 a.m. ET
Operator
Source Fool.com